Covaxin 50% Effective When Delta Dominated: Lancet Study |
Journal Updates
eMediNexus Coverage from: 
Covaxin 50% Effective When Delta Dominated: Lancet Study

0 Read Comments                

According to the first real-world evaluation of Covaxin, published in The Lancet Infectious Diseases, two doses of the vaccine appeared to be 50% effective against symptomatic disease.Results of an interim study published recently in The Lancet had shown that two doses of the vaccine were 77.8% effective against symptomatic disease and there were no serious safety concerns. The latest study evaluated 2,714 hospital workers at the All India Institute of Medical Sciences (AIIMS) in Delhi, between ...
To read the complete article ,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now